Skip to main content

Table 2 Association between the expression of YAP/TAZ and Wnt pathway mutations (N = 86)

From: Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

 

WNT

p-value

WT

MUT

N (%)

N (%)

TAZneg

39 (76.5)

12 (23.5)

0.008 (Chi-squared)

TAZpos

17 (48.6)

18 (51.4)

 

YAPneg

7 (70.0)

3 (30.0)

0.999 (Fisher)

YAPpos

49 (64.5)

27 (35.5)